Acute myocardial infarction care in the UK was associated with higher 30-day mortality compared to Sweden (10.5% vs 7.6%; adjusted mortality ratio 1.37, 95% CI 1.30-1.45).
Cohort (n=510,863)
Yes
Does acute myocardial infarction care in Sweden compared to the UK improve 30-day all-cause mortality?
Short-term mortality following acute myocardial infarction was significantly lower in Sweden compared to the UK, highlighting the population-level impact of earlier and more extensive uptake of primary PCI and secondary prevention medications.
Relative Risk: 1.37 (95% CI 1.3–1.45)
Absolute Event Rate: 10.5% vs 7.6%
BACKGROUND: International research for acute myocardial infarction lacks comparisons of whole health systems. We assessed time trends for care and outcomes in Sweden and the UK. METHODS: We used data from national registries on consecutive patients registered between 2004 and 2010 in all hospitals providing care for acute coronary syndrome in Sweden and the UK. The primary outcome was all-cause mortality 30 days after admission. We compared effectiveness of treatment by indirect casemix standardisation. This study is registered with ClinicalTrials.gov, number NCT01359033. FINDINGS: We assessed data for 119,786 patients in Sweden and 391,077 in the UK. 30-day mortality was 7·6% (95% CI 7·4-7·7) in Sweden and 10·5% (10·4-10·6) in the UK. Mortality was higher in the UK in clinically relevant subgroups defined by troponin concentration, ST-segment elevation, age, sex, heart rate, systolic blood pressure, diabetes mellitus status, and smoking status. In Sweden, compared with the UK, there was earlier and more extensive uptake of primary percutaneous coronary intervention (59% vs 22%) and more frequent use of β blockers at discharge (89% vs 78%). After casemix standardisation the 30-day mortality ratio for UK versus Sweden was 1·37 (95% CI 1·30-1·45), which corresponds to 11,263 (95% CI 9620-12,827) excess deaths, but did decline over time (from 1·47, 95% CI 1·38-1·58 in 2004 to 1·20, 1·12-1·29 in 2010; p=0·01). INTERPRETATION: We found clinically important differences between countries in acute myocardial infarction care and outcomes. International comparisons research might help to improve health systems and prevent deaths. FUNDING: Seventh Framework Programme for Research, National Institute for Health Research, Wellcome Trust (UK), Swedish Association of Local Authorities and Regions, Swedish Heart-Lung Foundation.
Chung et al. (Wed,) conducted a cohort in Acute myocardial infarction (n=510,863). UK health system care vs. Swedish health system care was evaluated on All-cause mortality 30 days after admission (Mortality ratio 1.37, 95% CI 1.30-1.45). Acute myocardial infarction care in the UK was associated with higher 30-day mortality compared to Sweden (10.5% vs 7.6%; adjusted mortality ratio 1.37, 95% CI 1.30-1.45).